MIM gets FDA nod for more contours for Contour ProtegeAI

2020 07 09 20 52 8488 Mim Astro 2019 400

Medical imaging software developer MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for more features for its Contour ProtégéAI autocontouring software.

The clearance is for additional contours for use in the head and neck, thorax, prostate, and abdomen, as well as quality improvements to existing contours. Also, Contour ProtégéAI now supports both cloud-hosted and local deployment in the U.S.

Page 1 of 383
Next Page